BioNotebook: Trevi, Complexa raise VC cash; Deerfield commits $60m to KemPharm; Aradigm, Voyager deal news; IPO updates

The second quarter of 2014 started off with a surge in venture capital deals, but the momentum seems to have slowed a bit as the quarter gets closer to its end, with the exception of Trevi Therapeutics and Complexa, which recently announced a total of $38m in new capital.